IN2013CN00089A - - Google Patents

Info

Publication number
IN2013CN00089A
IN2013CN00089A IN89CHN2013A IN2013CN00089A IN 2013CN00089 A IN2013CN00089 A IN 2013CN00089A IN 89CHN2013 A IN89CHN2013 A IN 89CHN2013A IN 2013CN00089 A IN2013CN00089 A IN 2013CN00089A
Authority
IN
India
Prior art keywords
present
lactoferrin
wounds
fragments
lobe
Prior art date
Application number
Other languages
English (en)
Inventor
Benjamin David Ashby
Qian Garrett
Mark Willcox
Original Assignee
Holden Brien Vision Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010902932A external-priority patent/AU2010902932A0/en
Application filed by Holden Brien Vision Inst filed Critical Holden Brien Vision Inst
Publication of IN2013CN00089A publication Critical patent/IN2013CN00089A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IN89CHN2013 2010-07-01 2011-07-01 IN2013CN00089A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2010902932A AU2010902932A0 (en) 2010-07-01 Lactoferrin sequences, compositions and methods of wound treatment
PCT/AU2011/000826 WO2012000054A1 (en) 2010-07-01 2011-07-01 Lactoferrin sequences, compositions and methods of corneal wound treatment

Publications (1)

Publication Number Publication Date
IN2013CN00089A true IN2013CN00089A (enExample) 2015-07-03

Family

ID=45401232

Family Applications (1)

Application Number Title Priority Date Filing Date
IN89CHN2013 IN2013CN00089A (enExample) 2010-07-01 2011-07-01

Country Status (10)

Country Link
US (1) US20130101575A1 (enExample)
EP (1) EP2588128A4 (enExample)
JP (1) JP2013530990A (enExample)
CN (1) CN103037894A (enExample)
AU (1) AU2011274244A1 (enExample)
CA (1) CA2803932A1 (enExample)
IN (1) IN2013CN00089A (enExample)
SG (1) SG186841A1 (enExample)
TW (1) TW201204384A (enExample)
WO (1) WO2012000054A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20110606A1 (it) * 2011-11-16 2013-05-17 Ist Superiore Sanita Peptidi della lattoferrina per lo uso come inibitori ad ampio spettro dellainfezione da virus della influenza.
US11376311B2 (en) 2017-11-02 2022-07-05 Colorado Seminary, Owner and Operator of University of Denver Methods of treating microbial infection and inflammation
CN117024518B (zh) * 2023-08-29 2025-07-25 百葵锐(深圳)生物科技有限公司 一种生物活性肽及其应用
CN118146346B (zh) * 2024-05-09 2024-08-06 杭州岛屿星晴生物技术有限公司 一种仿生胎脂蛋白肽的制备方法及其产品和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0579830B1 (en) * 1990-11-13 1997-02-05 Santen Pharmaceutical Co., Ltd. Therapeutic agent for corneal lesion
SI2298338T1 (sl) * 2002-09-16 2012-11-30 Agennix Inc Laktoferinski sestavki in postopki za zdravljenjekožnih ran
US20090202574A1 (en) * 2004-11-19 2009-08-13 Jagat Rakesh Kanwar Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
EP1937298A4 (en) * 2005-10-14 2009-11-11 Auckland Uniservices Ltd USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES
NZ552316A (en) * 2006-12-22 2009-10-30 Fonterra Co Operative Group Dairy product and process

Also Published As

Publication number Publication date
SG186841A1 (en) 2013-02-28
EP2588128A1 (en) 2013-05-08
TW201204384A (en) 2012-02-01
CN103037894A (zh) 2013-04-10
AU2011274244A1 (en) 2013-01-10
US20130101575A1 (en) 2013-04-25
CA2803932A1 (en) 2012-01-05
EP2588128A4 (en) 2014-03-19
JP2013530990A (ja) 2013-08-01
WO2012000054A1 (en) 2012-01-05

Similar Documents

Publication Publication Date Title
NZ727516A (en) Treatment of ocular neovascularization using a recombinant virus containing a nucleic acid encoding a vegf inhibitor
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
MX351414B (es) Composicion farmaceutica para el tratamiento y/o prevencion de cancer pancreatico.
IN2013CN01340A (enExample)
IN2014KN02830A (enExample)
EP4414376A3 (en) Novel depsipeptide and uses thereof
WO2013186777A3 (en) Use of blocking agents of bone morphogenie protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
WO2015157469A3 (en) Polypeptide compositions with type vii collagen fibronectin type iii- like repeats and treatment methods for wound closure and healing
WO2014141210A3 (en) Multifunctional immature dental pulp stem cells and therapeutic applications
MY156275A (en) Compositions comprising tramadol and celecoxib in the treatment of pain
PH12012500773A1 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
CO6710913A2 (es) Uso de ácido lipasa lisosomal para tratar la deficiencia de ácido lipasa lisosomal en pacientes
GEP201606514B (en) Apoptosis inhibitors and usage thereof
SG10201406288SA (en) Multimeric forms of antimicrobial peptides
MX2012013606A (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas.
MX2013007995A (es) Peptidos derivados de lactoferrina humana y su uso.
MX2009000359A (es) Metodos paratratar y limitar trastornos fibroticos y queloides.
IN2013CN00089A (enExample)
MX2013002118A (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
EA200901061A1 (ru) Фармацевтические и косметические композиции для ускорения процесса заживления ран и других поверхностных повреждений
WO2014039074A3 (en) Therapeutic compositions and related methods
MX2011007462A (es) Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas.
BR112015011693A2 (pt) composições fibrinolíticas compreendendo bromelina e nattokinase para a prevenção e tratamento de estados flebotrombóticos
MX342459B (es) 2-oxo- y 2-tioxo-dihidroquinolin-3-carboxamidas sustituidas, como moduladores de kcnq2/3.
PH12013502563A1 (en) Dha and epa in the reduction of oxidative stress